FierceBiotech7h
Big Pharma layoff rounds jump 281% in '24, but overall industry rates similar to '23
Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds ...
FierceBiotech16h
iBio pens $29M biobucks deal with AstralBio for obesity med designed to preserve muscle mass
San Diego-based iBio has signed a backloaded agreement with its existing partner AstralBio for a preclinical anti-myostatin ...
FierceBiotech14h
Analysts predict M&A, IPO uptick in 2025 but don't expect 'floodgates to suddenly open'
Will 2025 be better? After another tough year, the answer to that question will shape the prospects of innumerable drug ...
FierceBiotech14h
Chutes & Ladders—Vincerx acquisition leads to C-suite shake-up
After being acquired by clinical-stage ADC company Oqory, Vincerx ended 2024 with a workforce reduction and C-suite clear-out ...
FierceBiotech12h
Investor pumps $3M into cash-strapped Cyclacel in return for CEO role
Investor David Lazar has come to the rescue of cash-strapped Cyclacel Pharmaceuticals, pumping $3 million into the biotech as ...
FierceBiotech11h
FDA completes first phase of study into potential metal exposure from tampons
In September of last year, the FDA said it had begun exploring the potential health effects of various metals that have been ...